about
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5Endocrine treatment in prostate cancerHormonal and Chemotherapeutic Systemic Therapy for Metastatic Prostate Cancer.Diethylstilboestrol for the treatment of prostate cancer: past, present and future.Herbal supplement PC-Spes for prostate cancer.Estrogens and aspects of prostate disease.Overview of the latest treatments for castration-resistant prostate cancer.The andrologist's contribution to a better life for ageing men: part 1.Exogenous estrogen and the risk of biliary tract cancer - a population-based study in a cohort of Swedish men treated for prostate cancer.Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort.Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells.Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate.A cohort study of digoxin exposure and mortality in men with prostate cancer.Hormone replacement therapy and longevity.Does Androgen Deprivation Therapy for Prostate Cancer Increase the Risk of Colorectal Cancer?
P2860
Q28181459-5C9838D7-A51A-46F5-98C8-EB0EB4A51712Q28277569-FA56D072-0352-498C-AC69-ACC4F1E4E397Q28378298-37270D30-64D5-4D69-880D-07ED0E20AC40Q33891545-ACC0BA78-498C-421C-A782-BB0DCCF06DF3Q34386403-64C1523B-8EF6-405C-90CD-00B9E6B7AB1AQ34615655-E8B097B4-6699-42C0-B41F-CD7032124291Q36697811-1EC2A232-88B3-4403-B780-19CC4051C966Q38116754-7ED60242-4770-404C-91E3-43A3AF2F2702Q40513531-6F1D6269-14C2-4037-8666-BCFE723BA06EQ40757045-4C2DE2C0-054F-4B66-9E93-AE91D9E3BD3AQ41675513-0C232EF4-0954-4C7F-9DFA-23766B189562Q42508411-53C7BFAE-2AC9-4285-B961-9C4564F0C092Q44124776-071D7359-BAEA-485C-880F-957956C8AC62Q46784756-F8633F66-1820-4436-AF33-D816FF947D70Q47797325-BB545B83-A718-4A0C-BF30-30A8794388D4Q49145162-0DB2B556-4CE1-4C17-85B0-088C4821F693Q50852929-3DCB1719-9336-4AFD-B935-E25086724738
P2860
description
article
@en
im Dezember 1995 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1995
@uk
ലേഖനം
@ml
name
Estrogens in the Treatment of Prostate Cancer
@en
Estrogens in the Treatment of Prostate Cancer
@nl
type
label
Estrogens in the Treatment of Prostate Cancer
@en
Estrogens in the Treatment of Prostate Cancer
@nl
prefLabel
Estrogens in the Treatment of Prostate Cancer
@en
Estrogens in the Treatment of Prostate Cancer
@nl
P1476
Estrogens in the Treatment of Prostate Cancer
@en
P2093
E. David Crawford
R. Lee Cox
P304
P356
10.1016/S0022-5347(01)66670-9
P407
P577
1995-12-01T00:00:00Z